Press release
Erythropoietin Drugs Market Update 2023: Revenue to Cross USD 14.41 Billion 2028 | CAGR of 5.7%
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/59
Drivers of growth: The growth of the market is driven by factors such as the increasing prevalence of chronic kidney diseases, the rise in the number of cancer patients undergoing chemotherapy, and the growing geriatric population.
Types of erythropoietin drugs: The two major types of erythropoietin drugs are biosimilars and biologics. Biosimilars are expected to dominate the market due to their cost-effectiveness compared to biologics.
Application areas: Erythropoietin drugs are primarily used in the treatment of anemia caused by chronic kidney disease, cancer, and other diseases. They are also used to reduce the need for blood transfusions during surgeries.
Regional analysis: North America held the largest share of the market in 2020, followed by Europe and Asia Pacific. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period.
Market Segmentation:
On the basis product type, epoetin-alfa segment is anticipated to grow with the highest revenue throughout the forecast period, owing to increase in sales of Epogen, which is the top selling brand of erythropoietin, developed by Amgen. Epogen indicated notable growth in the U.S. market as Amgen procured patent protection for this product.
By application, the kidney disorders (ESRD and Dialysis) segment accounted for a major share in 2020, and is expected to exhibit a prominent growth rate during the forecast period, owing to increase in cases of patients with kidney disease. Furthermore, ESRD is majorly responsible for prescription of EPO treatment among renal disease patients.
Request for Customization -
https://www.alliedmarketresearch.com/request-for-customization/59
Competitive Landscape:
AMGEN INC.
JOHNSON AND JOHNSON
ROCHE DIAGNOSTICS
HOSPIRA INC.
LG LIFE SCIENCES LTD.
BIOCON
INTAS PHARMACEUTICALS
TEVA PHARMACEUTICAL INDUSTRIES LTD.
RANBAXY LABORATORIES LTD.
CELLTRION, INC
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/59
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Browse more latest healthcare reports:
Topical Oxygen Therapy Market https://www.alliedmarketresearch.com/topical-oxygen-therapy-market-A16966
Hemostats Market https://www.alliedmarketresearch.com/hemostats-market-A16840
Companion Animal Diagnostics Market https://www.alliedmarketresearch.com/companion-animal-diagnostics-market-A11127
Radiosurgery Systems Market https://www.alliedmarketresearch.com/radiosurgery-systems-market-A14841
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erythropoietin Drugs Market Update 2023: Revenue to Cross USD 14.41 Billion 2028 | CAGR of 5.7% here
News-ID: 3077595 • Views: …
More Releases from Allied Market Research
Luxury Yacht Market Forecast 2031: Reaching USD 12.8 billion with 8.0% CAGR
According to a new report published by Allied Market Research, titled, "Luxury Yacht Market by Size, Type, and Material: Global Opportunity Analysis and Industry Forecast, 2022-2031," the luxury yacht market size was valued at $5.8 billion in 2020 and is expected to reach $12.8 billion by 2031, registering a CAGR of 8.0% from 2022 to 2031.In terms of volume, Europe occupied around two-thirds of the market share for 2020.
Get…
Budget Hotels Market reach nearly USD 430.9 billion by 2032, exhibiting a robust …
According to the report, the global budget hotels market size was valued at $276.3 billion in 2022, and is projected to reach $430.9 billion by 2032, growing at a CAGR of 4.1% from 2023 to 2032.
Request The Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/190458
A budget hotel is a type of hotel in the hospitality industry. Budget hotels cater to travelers who are looking for affordable accommodation options without compromising…
Tactical Footwear Market Set to Achieve a Valuation of US$ 2.9 billion, Riding o …
According to a new report published by Allied Market Research, titled, "Tactical Footwear Market," The tactical footwear market was valued at $1.6 billion in 2021, and is estimated to reach $2.9 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031.
Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/13437
Tactical footwear refers to a type of specialized footwear designed for use in high-stress situations such as…
Destination Management Service Market Size Forecasted to Grow at 6.8% CAGR, Reac …
The destination management service market was valued at $3.6 billion in 2022, and is estimated to reach $6.9 billion by 2032, growing at a CAGR of 6.8% from 2023 to 2032.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/111278
Destination management services involve a variety of professional services offered by DMOs or DMCs to enhance the travel experience. Moreover, owing to growth in awareness regarding environmental…
More Releases for Erythropoietin
Erythropoietin (EPO) Drugs Market: An Overview
Introduction:
Erythropoietin (EPO) is a glycoprotein hormone that plays a crucial role in regulating red blood cell production (erythropoiesis) in the body. EPO drugs are synthetic versions of this hormone used to treat anemia, particularly in patients with chronic kidney disease (CKD), cancer, HIV, and other critical conditions that impact red blood cell production. EPO drugs help maintain adequate hemoglobin levels, improving the quality of life for patients by reducing the…
Erythropoietin Drugs Market Size, Opportunities 2022-2030
The Erythropoietin Drugs Market. The report delves into current trends, growth drivers, competitive landscape, and future forecasts, providing invaluable insights for stakeholders looking to understand the dynamics of this rapidly evolving sector. The global erythropoietin drugs market is poised for substantial growth, and the insights provided in this report are crucial for navigating this promising landscape.
-------------------------------------------------------------------------------------------------------------------
REQUEST A $1000 DISCOUNT ON CREDIT CARD PURCHASE: https://www.acumenresearchandconsulting.com/inquiry-before-buying/2675
-------------------------------------------------------------------------------------------------------------------
Market Overview:
The global erythropoietin drugs market was…
Erythropoietin Drugs Market - Revitalizing Lives: Erythropoietin Drugs for Enhan …
Newark, New Castle, USA: The "Erythropoietin Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Erythropoietin Drugs Market: https://www.growthplusreports.com/report/erythropoietin-drugs-market/8627
This latest report researches the industry structure, sales, revenue,…
Erythropoietin Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Erythropoietin market.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Click to view the…
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms of…
European Erythropoietin Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title European Erythropoietin Market Outlook 2022 to its growing collection of premium market research reports.
Erythropoietin drugs are protein therapeutics, which is used to treat various types of anaemia. These drugs play a significant role in treating CKD related anaemia and cancer related anaemia. Since its inception, the erythropoietin drugs market has witnessed various technological advancements, which have resulted in development of…
